Conjupri
These highlights do not include all the information needed to use CONJUPRIsafely and effectively. See full prescribing information for CONJUPRI. CONJUPRI (levamlodipine) tablets, for oral use.Initial U.S. Approval: 2019
c3cca66e-348a-43e8-8f96-e995104dae3d
HUMAN PRESCRIPTION DRUG LABEL
Nov 14, 2023
CSPC Ouyi Pharmaceutical Co. Ltd
DUNS: 421303775
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
levamlodipine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
levamlodipine
Product Details
FDA regulatory identification and product classification information